Masaryk University
| Address: | Žerotínovo nám. 617/9, 601 77 Brno, Rector's Office |
|---|
| phone: | +420 549 49 1111 |
|---|---|
| e-mail: |
| Company identification number: | 00216224 |
|---|---|
| VAT identification number: | CZ00216224 |
| Data Box ID: | 9tmj9e4 |
| Bank Account: | Komerční banka, a.s., Nám. Svobody 92/21, 602 00 Brno |
|---|---|
| Account number/Bank ID code: 85636621/0100 | |
| IBAN: CZ43 0100 0000 0000 8563 6621 | |
| SWIFT (=BIC): KOMBCZPPXXX |
Total number of publications: 1864
Articles
-
Trace Amine-associated Receptor 1 Agonists for Treatment of Substance use Disorder: Evidence from Rodent Behavioral Studies
CURRENT NEUROPHARMACOLOGY, year: 2026, DOI
-
Tracing the origins : Isotopic evidence from early medieval lead ingots from Great Moravian hillforts in Slovakia
JOURNAL OF ARCHAEOLOGICAL SCIENCE-REPORTS, year: 2026, volume: 71, edition: 1, DOI
-
Tracing the origins of Stradivari's resonance wood
DENDROCHRONOLOGIA, year: 2026, volume: 95, edition: February, DOI
-
Tracking biodegradable microplastics: Mobility in agricultural soils under different environmental conditions
Journal of Hazardous Materials, year: 2026, volume: 510, edition: June 2026, DOI
-
Tradice nebo modernita? Působení české exilové organizace Opus bonum v kontrastu s Českou duchovní službou v Německu před rokem 1989
ČESKÝ ČASOPIS HISTORICKÝ, year: 2026
-
Translating Russian modal predicatives: the case of можно in Czech and Polish literary texts
STUDI SLAVISTICI, year: 2026, volume: XXIII, edition: 1, DOI
-
Translational control of AMPK activity in melanoma
Cell Communication and Signaling, year: 2026, volume: 24, edition: 1, DOI
-
Transmembrane Transport of cAMP and AMP Using a Two Component Small Molecule Transport System
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, year: 2026, volume: 65, edition: 4, DOI
-
Travel Recommendations of Tomorrow: Generative Artificial Intelligence and Travel Planning
Journal of Consumer Behaviour, year: 2026, volume: 25, edition: 3, DOI
-
Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results
Leukemia, year: 2026, volume: 40, edition: 3, DOI